GSK

Consumer Health Firm Haleon Posts 16.1% Jump In Quarterly Sales

Haleon, the former consumer health arm of GSK, has reported a 16.1% increase in third-quarter reported revenue as it raised prices, and lifted its sales ou...

Haleon Sees Revenue Up 13.4% In First Half

British consumer healthcare company Haleon, which GSK recently officially spun off, has reported revenue growth of 13.4% (up 11.6% in t), to £5.2 bil...

Haleon Posts Revenue Growth In First Half

British consumer healthcare company Haleon, which GSK recently officially spun off, has posted a trading update for the six months ended 30 June 2022.

GSK Announces Board And Committee Changes

Global biopharma company GSK has announced a number of changes to its board and committees, which are set to take effect immediately following the demerger...

GSK Spins Off Haleon In Biggest European Listing For A Decade

GSK has officially spun off its consumer health business, Haleon, in the biggest listing in Europe for more than a decade.

GSK Spins Off Consumer Health Business Worth Up To $57bn

British drugmaker GSK will spin off its consumer health business Haleon worth up to an estimated £48 billion ($57 billion) on Monday in the biggest l...

Pfizer Set To Exit GSK's Consumer Health Arm After Spin-Off

Pfizer plans to exit its 32% stake in Haleon, its consumer health joint venture with British drugmaker GSK, after the business is spun off as an independen...

GSK Says Consumer Arm Spin-Off 'On Track', Stands By Forecasts

Britain's GSK beat analyst expectations for its first-quarter results on Wednesday and stood by its forecasts for 2022, ahead of the planned listing of its...